Category: Wall Street BeatSyndicate content

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Sientra prices $75m IPO

October 29, 2014 by Brad Perriello

Breast implant maker Sientra prices its initial public offering at $15 per share.

Sientra prices $75m IPO

Breast implant maker Sientra priced its initial public offering at $15 per share, saying it plans to issue 5 million shares for a total of $75 million.

Sientra, which also has designed implants for the buttocks, calf, pectoral region and face, has backers including Abingworth Bioventures, OrbiMed and Clarus Lifesciences.

Alere to sell Alere Health unit to Optum for $600m

October 28, 2014 by Val Kennedy

Alere says it plans to sell its health-management unit to Optum for $600 million in cash in order to focus on its core rapid diagnostics business.

Alere to sell Alere Health unit to Optum for $600m

Alere agreed to sell Alere Health, its health-management unit, to health-services provider Optum for $600 million in cash in order to focus on its core rapid diagnostics business.

Nevro sets range for IPO of up to $106m

October 28, 2014 by Brad Perriello

Nevro Corp. sets the per-share price range for its pending initial public offering, which would raise more than $106 million at the high end.

Nevro sets range for IPO of up to $106m

Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.

Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.

Skyline Medical conducts 1-for-75 reverse stock split

October 28, 2014 by Val Kennedy

Skyline Medical conducts a 1-for-75 reverse stock split, reducing the number of outstanding shares to approximately 3 million.

Skyline Medical conducts 1-for-75 reverse stock split

UPDATE: Valeant ready to raise Allergan bid to at least $200/share

October 27, 2014 by MassDevice

Valeant Pharmaceuticals says it's ready to up the ante in its hostile takeover bid for Allergan.

UPDATE: Valeant ready to raise Allergan bid to at least $200/share

Exclusive: Salesforce to make big push into healthcare industry

October 27, 2014 by MassDevice

Salesforce is reportedly ramping up to enter the healthcare market in a big way.

Exclusive: Salesforce to make big push into healthcare industry
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp